Ønsker du å legge inn bud på offentlige anbud? Se vår TaaS-tjeneste for anbudsklargjøring
Anbud

Amgros 2027 1.476.a

Åpen
Frist
27 dager igjen
mai 12, 2026
Kontraktsdetaljer
Kategori
Annet
Referanse
00207279-2026
Verdi
kr5,640,000
Sted
Hovedstaden, Denmark
Publisert
april 08, 2026
Organisasjon
CPV-kode
Prosjektets tidslinje

Anbud publisert

mars 26, 2026

Frist for spørsmål

mai 05, 2026

Frist for innlevering

mai 12, 2026

Budsjett
kr5,640,000
Varighet
Ikke spesifisert
Sted
Hovedstaden
Type
Annet
75
Kvalitetsscore/100
God

Opprinnelig anbudsbeskrivelse

Amgros I/S (Amgros) er et interessentskap med de 5 regionene som interessenter. Amgros ønsker å inngå rammeavtaler for legemidlene som fremgår av de enkelte delkontraktene nedenfor, med henblikk på å forsyne interessentenes sykehusapoteker med legemidler samt eventuelt videresalg til Færøyene og Grønland. Amgros videreselger legemidlene til sykehusapotekene til Amgros' innkjøpspris med et tillegg. Rammeavtalene er ikke-eksklusive. Rammeavtalene inngås uten kjøpsplikt, og sykehusapotekene i

Kjør risikoanalyse

Identifiser potensielle risikoer, inkonsekvenser og varsellamper i alle anbudsunderlag. Få en detaljert risikorapport med alvorlighetsgrader og anbefalinger for risikoreduserende tiltak.

Logg inn

Vinnstrategi

Få en AI-drevet vinnerstrategi skreddersydd for dette anbudet. Inkluderer sannsynlighetsscore for å vinne, viktige muligheter og utfordringer, anbefalte fokusområder for tilbudet, innsikt i konkurranseposisjonering og handlingsrettede anbefalinger for å maksimere sjansene dine.

Logg inn

Konkurrenter

Oppgrader for å se hvilke selskaper som sannsynligvis vil legge inn tilbud på dette anbudet, basert på historiske anskaffelsesdata.

Logg inn

Krav og kvalifikasjoner

8 krav på tvers av 5 kategorier

Innlevering (1)
Obligatorisk (1)
Overholdelse (4)
Teknisk (1)
Finansiell (1)
SUBMISSION REQUIREMENTS1
--Bids must be submitted by the deadline: 2026-05-12 10:00:00.
MANDATORY EXCLUSION GROUNDS1
--No specific mandatory exclusion grounds are detailed in the provided text.
ELIGIBILITY REQUIREMENTS4
--Bidders must be able to supply the pharmaceuticals listed in the individual sub-contracts.
--The framework agreements are non-exclusive.
--Framework agreements are entered into without a purchase obligation.
TECHNICAL CAPABILITY REQUIREMENTS1
--No specific technical capability requirements are detailed in the provided text.
FINANCIAL REQUIREMENTS1
--No specific financial requirements are detailed in the provided text.

Forhåndsvisning av krav

Registrer deg for å se komplette krav og analyser

Dokumenter

Få AI-genererte sammendrag av alle anbudsunderlag. Forstå raskt hva hvert dokument inneholder uten å lese hundrevis av sider – som dekker omfang, betingelser, evalueringskriterier og viktige forpliktelser.

Logg inn
75
God

Anbudskvalitetsscore

This tender is generally well-structured with clear basic information and a defined CPV code. However, it lacks specific details on evaluation criteria and technical/financial requirements, impacting completeness and practicality.

Poengfordeling

Juridisk samsvar75/100

The tender appears to comply with general procurement regulations, including the use of a proper CPV code and an open procedure. Deadlines are specified, though their reasonableness is debatable given the limited information. No disputes are indicated. The procedure is classified as 'competition' but lacks a specific code, which is a minor oversight.

Klarhet80/100

The description of the tender's purpose and the nature of the framework agreements (non-exclusive, no purchase obligation) is clear. However, the absence of specified evaluation criteria and detailed technical/financial requirements leaves significant ambiguity for potential bidders.

Missing evaluation criteria
Fullstendighet70/100

Most basic information is present, including title, reference, organization, estimated value, and submission deadline. However, crucial details such as contract duration, specific technical and financial requirements, and detailed exclusion grounds are missing. The availability of tender documents is noted, but their content is not summarized.

Missing contract duration
No specific technical capability requirements detailed
Rettferdighet85/100

The tender is an open procedure, and the estimated value is disclosed. The non-exclusive nature of the framework agreements and the lack of purchase obligation for hospital pharmacies promote fairness. However, the lack of detailed evaluation criteria could lead to subjective assessments. Access to documents is implied but not explicitly detailed.

Missing evaluation criteria
Praktisk gjennomførbarhet65/100

The tender specifies e-procurement, which is positive. However, the absence of a contract start date and financing information, along with the lack of detailed technical and financial requirements, reduces its practicality for bidders. The submission deadline, while present, might be considered short given the information gaps.

Missing contract start date
No financing information
Datakonsistens90/100

Key fields such as title, reference, organization, value, and deadline are populated. The dates are logical, and there are no indications of suspension or disputes. The CPV code is appropriate for the described procurement.

Bærekraft50/100

There is no explicit mention of green procurement, social aspects, or innovation within the provided tender information. This suggests a lack of focus on sustainability criteria.

Not green procurement
No social criteria

Styrker

Clear basic information and title
Defined CPV code
Open procedure and e-procurement indicated
Non-exclusive framework agreements

Bekymringer

Missing detailed evaluation criteria
Lack of specific technical and financial requirements
Absence of contract duration and start date
Limited sustainability considerations

Anbefalinger

1. Provide detailed evaluation criteria to ensure transparency.
2. Specify technical and financial requirements for bidders.
3. Include information on contract duration and start date.

Forhåndsvisning av AI-score

Registrer deg for å se komplette krav og analyser

Fullstendig analyse av kvalitetsresultat
Detaljert nedbrytning av delresultater
Innsikt i styrker og bekymringer
Strategiske anbefalinger

Ingen kredittkort kreves • Oppsett på 2 minutter

Legg til i pipeline